Insiders · MAZE

MAZE insider transactions

Maze Therapeutics Inc. (MAZE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MAZE

• 23d
  SEC Form 4 filed by Bernstein Harold

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 23d
  SEC Form 4 filed by Bachrodt Amy

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 24d
  SEC Form 4 filed by Dandekar Atul

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 25d
  SEC Form 4 filed by Kumar Neil

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 25d
  SEC Form 3 filed by new insider Kumar Neil

  3 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 36d
  SEC Form 4 filed by Bernstein Harold

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 44d
  President, R&D & CMO Bernstein Harold exercised 30,000 shares at a strike of $10.42 and sold $1,513,560 worth of shares (30,000 units at $50.45) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 53d
  SEC Form 4 filed by GC and Corp. Secretary Courtney Phillips

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 53d
  SEC Form 4 filed by Chief Executive Officer Coloma Jason V

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 80d
  President, R&D & CMO Bernstein Harold exercised 15,000 shares at a strike of $10.42 and sold $690,334 worth of shares (15,000 units at $46.02) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 80d
  SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $230,219 worth of shares (5,000 units at $46.04) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 82d
  CSBO Dandekar Atul exercised 7,500 shares at a strike of $10.42 and sold $331,990 worth of shares (7,500 units at $44.27) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 89d
  SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $227,612 worth of shares (5,000 units at $45.52) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 106d
  President, R&D & CMO Bernstein Harold exercised 25,156 shares at a strike of $10.42 and sold $1,011,299 worth of shares (25,156 units at $40.20) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 107d
  Director Sohn Catherine A. exercised 29,413 shares at a strike of $10.42 and sold $1,149,054 worth of shares (29,413 units at $39.07) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 109d
  President, R&D & CMO Bernstein Harold exercised 4,844 shares at a strike of $10.42 and sold $195,668 worth of shares (4,844 units at $40.39) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 109d
  SVP, Finance Bachrodt Amy exercised 5,000 shares at a strike of $10.42 and sold $195,754 worth of shares (5,000 units at $39.15) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 115d
  CSBO Dandekar Atul exercised 72,500 shares at a strike of $10.42 and sold $2,940,799 worth of shares (72,500 units at $40.56) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 115d
  President, R&D & CMO Bernstein Harold exercised 45,000 shares at a strike of $10.42 and sold $1,825,355 worth of shares (45,000 units at $40.56) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 115d
  SVP, Finance Bachrodt Amy exercised 15,000 shares at a strike of $10.42 and sold $606,173 worth of shares (15,000 units at $40.41) (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 155d
  Director Homcy Charles J acquired 1,489 shares, increasing direct ownership by 5% to 31,113 units (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 171d
  Large owner Third Rock Ventures Iv, L.P. disposed of 1,600,000 shares (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 180d
  Director Homcy Charles J gifted 28,423 shares, decreasing direct ownership by 49% to 29,624 units (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 200d
  SEC Form 4 filed by Director Hoppenot Herve

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 200d
  SEC Form 3 filed by new insider Hoppenot Herve

  3 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by GC and Corp. Secretary Courtney Phillips

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by CSBO Dandekar Atul

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Chief Executive Officer Coloma Jason V

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by President, R&D & CMO Bernstein Harold

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by SVP, Finance Bachrodt Amy

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Spiegelman Daniel K

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Sohn Catherine A.

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Scheller Richard H

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Lim Jonathan E

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Kathiresan Sekar

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Homcy Charles J

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Exter Neil

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 213d
  SEC Form 4 filed by Director Andrews Nancy C

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 221d
  Director Scheller Richard H sold $464,035 worth of shares (20,744 units at $22.37), closing all direct ownership in the company (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 235d
  SEC Form 4 filed by Chief Financial Officer Tahir Misbah

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 235d
  SEC Form 3 filed by new insider Tahir Misbah

  3 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 249d
  SEC Form 4 filed by Director Exter Neil

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 445d
  Large owner Third Rock Ventures Iv, L.P. converted options into 6,713,588 shares (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 445d
  Director Lim Jonathan E converted options into 307,956 shares (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)
• 445d
  Director Homcy Charles J converted options into 36,946 shares, increasing direct ownership by 104% to 58,047 units (SEC Form 4)

  4 - Maze Therapeutics, Inc. (0001842295) (Issuer)